Search Results - "Mairs, Simon"

Small Biopsies Misclassify up to 35% of PD-L1 Assessments in Advanced Lung Non-Small Cell Lung Carcinomas by Bigras, Gilbert, Mairs, Simon, Swanson, Paul E, Morel, Didier, Lai, Raymond, Izevbaye, Iyare

“…Pembrolizumab is an FDA-approved immune-checkpoint (IC) inhibitor that targets programmed cell death protein PD-1, and recent phase III trials have…”
Get full text

Abstract P3-08-52: Systemic toxicities of trastuzumab-emtansine predict tumor response in HER2+ metastatic breast cancer by Tang, Shou-Ching, Capra, Carter Louis, Ajebo, Germame H, Mairs, Simon, Meza-Junco, Judith, Hillegass, William B., Craft, Barbara S., Zhu, Xiaofu

“…Abstract Introduction: The plant alkaloid Maytansine and its derivatives with anti-microtubule activity failed in early trials due to significant toxicity.When…”
Get full text

Systemic toxicities of trastuzumab‐emtansine predict tumor response in HER2+ metastatic breast cancer by Tang, Shou‐Ching, Capra, Carter L., Ajebo, Germame H., Meza‐Junco, Judith, Mairs, Simon, Craft, Barbara S., Zhu, Xiaofu, Maihle, Nita, Hillegass, William B.

“…The mechanism by which trastuzumab‐emtansine (T‐DM1) causes systemic toxicities apart from trastuzumab alone is currently unknown. We hypothesized that the…”
Get full text

Detergent: an alternative approach to traditional bone cleaning methods for forensic practice by Mairs, Simon, Swift, Benjamin, Rutty, Guy N

“…Osteological assessment of human remains forms an essential part of forensic work, especially during the examination of extensively decomposed, dismembered, or…”
Get full text